Lack of substrate inhibition in a monomeric form of human cytosolic SULT2A1

Hormone Molecular Biology and Clinical Investigation

Volumn 3, Issue 1, 2010, Pages 367-374

  Cook, Ian T ^a   Falany, Charles N ^a   Leyh, Thomas S ^b   Kadlubar, Susan A ^c  

^a University of Alabama at Birmingham   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

dehydroepiandrosterone; dimerization; maltose binding protein; substrate inhibition; sulfation; sulfotransfe rase; SULT2A1

Indexed keywords

HYBRID PROTEIN; MALTOSE BINDING PROTEIN; MONOMER; SULFOTRANSFERASE; SULFOTRANSFERASE 2A1; UNCLASSIFIED DRUG;

ALLOSTERIC SITE; ARTICLE; CYTOSOL; DIMERIZATION; ENZYME INHIBITION; PRIORITY JOURNAL; SIZE EXCLUSION CHROMATOGRAPHY; SULFATION;

EID: 85015222373     PISSN: 18681883     EISSN: 18681891     Source Type: Journal    
DOI: 10.1515/HMBCI.2010.041     Document Type: Article

References (24)

1. Comer KA., Falany JL., Falany CN. Cloning and expression of human liver dehydroepiandrosterone sulphotransferase. Biochem J 1993;289:233-40.
2. Falany CN., Vazquez ME., Kalb JM. Purification and characterization of human liver dehydroepiandrosterone sulphotransferase. Biochem J 1989;260:641-6.
3. Falany CN., Wheeler J., Oh TS., Falany JL. Steroid sulfation by expressed human cytosolic sulfotransferases. J Steroid Biochem Mol Biol 1994;48:369-75.
4. Comer KA., Falany CN. Immunological characterization of dehydroepiandrosterone sulfotransferase from human liver and adrenal. Mol Pharmacol 1992;41:645-51.
5. Falany C., Comer K., Dooley T., Glatt H. Human dehydroepiandrosterone sulfotransferase: purification., molecular cloning., and characterization. Ann NY Acad Sci 1995;774:59-72.
6. Falany CN. Enzymology of human cytosolic sulfotransferases. FASEB J 1997;11:206-16.
7. Fang HL., Strom SC., Ellis E., Duanmu Z., Fu J., Duniec-Dmu-chowski Z., Falany CN., Falany JL., Kocarek TA., Runge-Morris M. Positive and negative regulation of human hepatic hydroxysteroid sulfotransferase (SULT2A1) gene transcription by rifampicin: roles of hepatocyte nuclear factor 4alpha and pregnane X receptor. J Pharmacol Exp Ther 2007;323:586-98.
8. Fang HL., Strom SC., Cai H., Falany CN., Kocarek TA., Runge-Morris M. Regulation of human hepatic hydroxysteroid sulfo-transferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor. Mol Pharmacol 2005;67:1257-67.
9. Cook I., Leyh T., Kadlubar S., Falany C. Structural rearrangement of SULT2A1: effects on dehydroepiandrosterone and raloxifene sulfation. Horm Mol Biol Clin Invest 2010;1:81-7.
10. Zhang H., Varlamova O., Vargas FM., Falany CN., Leyh TS., Var-malova O. Sulfuryl transfer: the catalytic mechanism of human estrogen sulfotransferase. J Biol Chem 1998;273:10888-92.
11. Barnett AC., Tsvetanov S., Gamage N., Martin JL., Duggleby RG., McManus ME. Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3. J Biol Chem 2004; 279:18799-805.
12. Lu LY., Hsieh YC., Liu MY., Lin YH., Chen CJ., Yang YS. Identification and characterization of two amino acids critical for the substrate inhibition of human dehydroepiandrosterone sul-fotransferase (SULT2A1). Mol Pharmacol 2008;73:660-8.
13. Weitzner B., Meehan T., Xu Q., Dunbrack RL Jr. An unusually small dimer interface is observed in all available crystal structures of cytosolic sulfotransferases. Proteins 2009;75:289-95.
14. Allali-Hassani A., Pan PW., Dombrovski L., Najmanovich R., Tempel W., Dong A., Loppnau P., Martin F., Thornton J., Edwards AM., Bochkarev A., Plotnikov AN., Vedadi M., Arrowsmith CH. Structural and chemical profiling of the human cytosolic sulfotransferases. PLoS Biol 2007;5:e97.
15. Cook IT., Duniec-Dmuchowski Z., Kocarek TA., Runge-Morris M., Falany CN. 24-Hydroxycholesterol sulfation by human cytosolic sulfotransferases: formation of monosulfates and disulfates., molecular modeling., sulfatase sensitivity., and inhibition of liver x receptor activation. Drug Metab Dispos 2009; 37:2069-78.
16. Bell J., Bell E., editors. Proteins and enzymes. Englewood Cliffs., NJ: Prentice-Hall Inc., 1988.
17. Petrotchenko EV., Pedersen LC., Borchers CH., Tomer KB., Negishi M. The dimerization motif of cytosolic sulfotransfe-rases. FEBS Lett 2001;490:39-43.
18. Pedersen LC., Petrotchenko EV., Negishi M. Crystal structure of SULT2A3, human hydroxysteroid sulfotransferase. FEBS Lett 2000;475:61-4.
19. Rehse PH., Zhou M., Lin SX. Crystal structure of human dehy-droepiandrosterone sulphotransferase in complex with substrate. Biochem J 2002;364:165-71.
20. Falany JL., Greer H., Kovacs T., Sorscher EJ., Falany CN. Elevation of hepatic sulphotransferase activities in mice with resistance to cystic fibrosis. Biochem J 2002;364:115-20.
21. Falany CN., Krasnykh V., Falany JL. Bacterial expression and characterization of a cDNA for human liver estrogen sulfotrans-ferase. J Steroid Biochem Mol Biol 1995;52:529-39.
22. Kakuta Y., Pedersen LC., Chae K., Song WC., Leblanc D., London R., Carter CW., Negishi M. Mouse steroid sulfotransferases: substrate specificity and preliminary X-ray crystallographic analysis. Biochem Pharmacol 1998;55:313-7.
23. Chang HJ., Shi R., Rehse P., Lin SX. Identifying androsterone (ADT) as a cognate substrate for human dehydroepiandroste-rone sulfotransferase (DHEA-ST) important for steroid home-ostasis: structure of the enzyme-ADT complex. J Biol Chem 2004;279:2689-96.
24. Gamage NU., Duggleby RG., Barnett AC., Tresillian M., Latham CF., Liyou NE., McManus ME., Martin JL. Structure of a human carcinogen-converting enzyme., SULT1A1. Structural and kinetic implications of substrate inhibition. J Biol Chem 2003;278: 7655-62.